소아에서의 지속적 신대체요법 = Continuous Renal Replacement Therapy in Pediatric

다국어 초록 (Multilingual Abstract)

Continous renal replacement therapy(CRRT) is becoming increasingly popular for the support of critically ill patients with acute renal failure, and the development of pump-driven volumetric-control CRRT machines with small extracorporeal volumes has lead to the widespread use of venovenous form of CRRT in pediatric field. Basic principles are diffusion and convection. CRRT is indicated in the hemodynamically unstable pediatric patients for hypervolemic anuric acute renal failure, electrolyte abnormalities, multiorgan failure, catabolic patients with increased nutritional needs and hyperammonemia, etc. To date, experiences are limited for pediatric CRRT, but current reports support that CRRT is feasible and useful in children and even infants, and the survival rate of the patients on CRRT is as same as adults. We describe the basic principles, equipments, methods and complications of CRRT, with special considerations on small children to meet the current need for CRRT.

참고문헌 (Reference)

1 "Ultrafiltration and modified ultrafiltration in pediatric open heart operations" 56 : 1518-1522, 2993

2 "The experiences of pump-driven continuous venovenous hemofiltration therapy in pediatric patients" 6 : 251-258, 2002

3 "Slow continuous therapies. In : Handbook of dialysis" Little brown and Company 199-230, 1994

4 "Pump-assisted continuous venovenous hemofiltration fot treating acute uremia" 33 (33): 157-158, 1988

5 "Overview of pediatric renal replacement therapy in acute renal failure" 27 : 781-785, 2003

6 "Outcome in children receiving continuous venovenous hemofiltration" 107 : 1309-1312, 2001

7 "Non-renal indications for continuous renal replacement therapy" 56 (56): 88-94, 1999

8 "Modalities of dialysis for acute renal failure" 9 : 469-475, 1996

9 "Higher renal replacement therapy dose delivery influences on drug therapy" 27 : 808-814, 2003

10 "Hemofiltration increases IL-6 clearance in early systemic inflammatory reponse syndrome but does not alter IL-6 and TNF alpha plasma concentrations" 23 : 878-884, 1997

11 "Hemofiltration in human sepsis:Evidence for elimination of immunomodulatory substances" 48 : 1563-1570, 1995

12 "Hemodialysis of the uremic child" 89 : 645-655, 1955

13 "Hemodialysis in pediatrics" 13 (13): 154-161, 1994

14 "Effects of different doses in CVVH on outcomes of acute renal failure:a perspective randomized trial" 356 : 26-30, 2000

15 "Cytokines clearance during venovenous hemofitration in the trauma patient" 30 : 483-488, 1997

16 "Continuous renal replacement therapy in critically ill pediatric patients" 28 (28): 28-34, 1996

17 "Continuous renal replacement therapy in children up to 10 kg" 41 : 984-989, 2003

18 "Continuous renal replacement therapies:an update" 32 : 185-207, 1998

19 "Congestive heart failure as an indication for continuous renal replacement therapy" 56 (56): 95-98, 1999

20 "Comparison of lactate and bicarbonate buffered hemofiltration fluids:use in critically ill patients" 12 : 1212-1217, 1997

21 "Arteriovenous hemofiltration:a new and simple method for treatment of overhydrated patients resistant to diuretics" 55 : 1121-1122, 1977

22 "Acid-base balance and replacement solutions in continuous renal replacement therapies" 53 (53): 156-159, 1998

23 "AN69 membrane reactions are pH dependent and preventable" 38 : 173-178, 2001

24 "AN 69 membrane and conversion enzyme inhibitors : prevention of anaphylactic shock by alkaline rinsing?" 13 : 135-136, 1992